MedMira Inc Total Liabilities
MedMira Inc total liabilities. Based on the latest financial reports, MedMira Inc (MIR) has total liabilities worth CA$27.92 Million CAD (≈ $20.19 Million USD) as of April 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check MedMira Inc (MIR) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of MedMira Inc (2000–2025)
Total liabilities of MedMira Inc from 2000 to 2025. This chart illustrates how MedMira Inc's total liabilities have evolved over time, based on quarterly financial data.
MedMira Inc Competitors by Total Liabilities
The table below lists competitors of MedMira Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Compania Introductora de Buenos Aires SA
BA:INTR
|
Argentina | AR$41.97 Billion |
|
The Navakij Insurance Public Company Limited
BK:NKI
|
Thailand | ฿3.28 Billion |
|
Duxton Farms Ltd
AU:DBF
|
Australia | AU$123.41 Million |
|
Winix Inc
KQ:044340
|
Korea | ₩463.08 Billion |
|
Reyna Silver Corp
V:RSLV
|
Canada | CA$1.59 Million |
|
Stria Lithium Inc
V:SRA
|
Canada | CA$111.99K |
|
TURBOMECANICA S.A.
RO:TBM
|
Romania | RON91.65 Million |
|
Metallic Minerals Corp
V:MMG
|
Canada | CA$861.37K |
Liability Composition Analysis (2000–2025)
This chart breaks down MedMira Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see MIR total assets.
Liquidity & Leverage Metrics
MedMira Inc Total Liabilities Ratios Explained
MedMira Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.06 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.14 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 8.21 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how MedMira Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for MedMira Inc (2000–2025)
The table below shows the annual total liabilities of MedMira Inc from 2000 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-07-31 | CA$26.24 Million ≈ $18.98 Million |
+8.86% |
| 2024-07-31 | CA$24.11 Million ≈ $17.44 Million |
+29.02% |
| 2023-07-31 | CA$18.68 Million ≈ $13.52 Million |
+15.43% |
| 2022-07-31 | CA$16.19 Million ≈ $11.71 Million |
-17.48% |
| 2021-07-31 | CA$19.61 Million ≈ $14.19 Million |
+3.46% |
| 2020-07-31 | CA$18.96 Million ≈ $13.71 Million |
+37.68% |
| 2019-07-31 | CA$13.77 Million ≈ $9.96 Million |
+17.70% |
| 2018-07-31 | CA$11.70 Million ≈ $8.46 Million |
+21.13% |
| 2017-07-31 | CA$9.66 Million ≈ $6.99 Million |
+13.20% |
| 2016-07-31 | CA$8.53 Million ≈ $6.17 Million |
-10.08% |
| 2015-07-31 | CA$9.49 Million ≈ $6.86 Million |
+11.21% |
| 2014-07-31 | CA$8.53 Million ≈ $6.17 Million |
-16.98% |
| 2013-07-31 | CA$10.28 Million ≈ $7.43 Million |
-12.00% |
| 2012-07-31 | CA$11.68 Million ≈ $8.45 Million |
-43.32% |
| 2011-07-31 | CA$20.61 Million ≈ $14.91 Million |
+19.58% |
| 2010-07-31 | CA$17.23 Million ≈ $12.47 Million |
+4.31% |
| 2009-07-31 | CA$16.52 Million ≈ $11.95 Million |
+11.82% |
| 2008-07-31 | CA$14.77 Million ≈ $10.69 Million |
-5.55% |
| 2007-07-31 | CA$15.64 Million ≈ $11.32 Million |
+29.77% |
| 2006-07-31 | CA$12.05 Million ≈ $8.72 Million |
+7.31% |
| 2005-07-31 | CA$11.23 Million ≈ $8.13 Million |
+48.44% |
| 2004-07-31 | CA$7.57 Million ≈ $5.47 Million |
+66.42% |
| 2003-07-31 | CA$4.55 Million ≈ $3.29 Million |
-57.93% |
| 2002-07-31 | CA$10.81 Million ≈ $7.82 Million |
+19.65% |
| 2001-07-31 | CA$9.03 Million ≈ $6.54 Million |
+31.06% |
| 2000-07-31 | CA$6.89 Million ≈ $4.99 Million |
-- |
About MedMira Inc
MedMira Inc., a biotechnology company, researches, develops, manufactures, and sells rapid diagnostics and technology platforms in North America, Europe, and internationally. The company offers Reveal HIV, a test that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or who… Read more